SRTS חוב כולל להון Sensus
Sensus Healthcare, Inc. (SRTS) is recognized as a leader in non-invasive therapy for skin neoplasms, offering safe outpatient solutions. Due to its focus on the domestic US market, the business is shielded from geopolitical risks, and the market trend visualized in monetary format on GURU.Markets shows a total debt-to-equity ratio of 0.01. Patents for emitters and FDA certification ensure a high barrier to entry.
פילוחי מדדים מקיפים ואנליטיקה עבור Sensus (SRTS)
A comparative analysis of this ratio allows investors to evaluate the deleveraging strategy by weighing total credit obligations against equity to determine the degree of financial autonomy. Stable cash flows from service maintenance and consumables within the Sensus Healthcare, Inc. (SRTS) ecosystem minimize over-leverage risks, which is reflected in the trend of the total liabilities-to-equity ratio.